Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06307717
Other study ID # PLAGH-DA-002
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 1, 2020
Est. completion date April 30, 2022

Study information

Verified date April 2024
Source Chinese PLA General Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

This study is a retrospective analysis of a large-scale multicentre prospective cohort study that investigates the impact of volatile anaesthetics on the incidence of postoperative depression and anxiety among elderly patients.


Description:

Studies have suggested volatile anaesthetics may alleviate depression and anxiety in patients. However, there is a paucity of research in this area. The investigatorswanted to determine the association between volatile anaesthetics and depression/anxiety in elderly patients within 7 days after surgery. This study retrospectively analysed data from a prospective database of patients aged 65 and above who underwent non-cardiac, non-neurosurgical elective surgery in 18 tertiary hospitals across 10 provinces in China. Patients receiving volatile anaesthetics received at least one volatile anaesthetic (sevoflurane, isoflurane, desflurane), and those who received non-volatile anaesthetics did not receive any volatile anaesthetic. Binary logistic regression analyses were conducted, and propensity score-matching (PSM) and subgroup analyses were also applied.


Recruitment information / eligibility

Status Completed
Enrollment 8000
Est. completion date April 30, 2022
Est. primary completion date October 31, 2021
Accepts healthy volunteers No
Gender All
Age group 65 Years and older
Eligibility Inclusion Criteria: Geriatric surgical patients =65 years old Non-selective cardiac surgery Non-neurosurgical Exclusion Criteria: 1. underwent reoperation within 7 days 2. ASA classification of ? or above 3. history of serious mental illness or long-term use of psychotropic drugs 4. patients either died or were transferred to the intensive care unit within 7 days of the surgery 5. subjects with missing covariate data

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
volatile anaesthetic (sevoflurane, isoflurane, desflurane)
Patients receiving volatile anaesthetics received at least one volatile anaesthetic (sevoflurane, isoflurane, desflurane), and those who received non-volatile anaesthetics did not receive any volatile anaesthetic.

Locations

Country Name City State
China Chinese PLA General Hospital Beijing Beijing

Sponsors (17)

Lead Sponsor Collaborator
Chinese PLA General Hospital Beijing Anzhen Hospital, Beijing Tsinghua Changgeng Hospital, Central South University, China-Japan Friendship Hospital, First Affiliated Hospital of Guangxi Medical University, First Affiliated Hospital of Xinjiang Medical University, Fudan University, Peking University First Hospital, Peking University People's Hospital, Sun Yat-sen University, Taihe Hospital, The Affiliated Hospital Of Guizhou Medical University, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Wuhan Union Hospital, China, Xiangya Hospital of Central South University, Zhejiang University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Depression Primary outcomes were depression Patient Health Questionnaire 9 (PHQ-9).The PHQ-9 is a nine-item questionnaire for screening on the presence of depressive symptoms and monitoring depression severity. Items were scored on a four-point scale with total scores ranging from zero to twenty-seven. Scores were defined as: =5 mild, =10 moderate, and =15 severe level of depression. The recommended screening cutoff was =10, corresponding with at least a moderate level of depression. The higher the score, the worse the situation. The total score ranges from 0 to 27, and higher scores indicate more depressive symptoms. Depression within 7 days of surgery
Secondary Anxiety The GAD-7 is a seven-item questionnaire for screening on the presence of generalized anxiety disorder and assessing its severity. Items were scored on a four-point scale with total scores ranging from zero to twenty-one. Scores were defined as: =5 mild, =10 moderate, and =15 severe anxiety. The recommended screening cutoff was =10, corresponding with at least a moderate level of anxiety. Higher scores mean more anxiety. Anxiety within 7 days of surgery
See also
  Status Clinical Trial Phase
Recruiting NCT03335644 - The NutriNet-Santé Study
Recruiting NCT05713578 - Efficacy and Safety of Apantamide Combined With Docetaxel and ADT vs. Apantamide Combined With ADT in Patients With High Tumor Burden mHSPC: a Multicenter and Prospective Cohort Study Early Phase 1
Completed NCT06362408 - Effect of Dexmedetomidine on Postoperative Mental Disorders and Long-term Survival in Elderly Patients
Completed NCT03388281 - Morbidity, Mortality and Gender Differences in Patients With Pacemakers N/A
Recruiting NCT05916287 - FAMILY INHERITANCE, GENE-GENE AND GENE-ENVIRONMENT INTERACTIONS IN THE FIELD OF CARDIOVASCULAR AND RENAL DISEASES. Fifth Visit of the STANISLAS Cohort N/A
Recruiting NCT05855720 - Nationwide Uniform Scientific Evaluation of Flexible and Integrated Treatment Projects From 2022 Onwards
Completed NCT05526599 - The Association of Marital Status With Kidney Cancer Surgery Morbidity
Completed NCT04373109 - Stroke Rehabilitation Outcome During COVID-19 Lockdown
Recruiting NCT04996342 - A Cohort Study of Chronic Cardiovascular Diseases